Showing results (351-360 of 386) with videos related to

Sort By:
Pageof 39
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
Biopreservation and Biobanking|March 19, 2025
Experts Speak Forum: Decarbonization for Green Biobanking-The Current Landscape and Challenges for the FutureKoh Furuta, Hanh Vu, Daniel Adamek, et al.
Urologic Oncology|June 9, 2018
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancerElisabeth E Fransen van de Putte, Wolfgang Otto, Arndt Hartmann, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
The Journal of Urology|July 25, 2025
A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyBernhard J Eigl, Arun Elangovan, Sunita Ghosh, et al.
European Urology|April 23, 2025
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Patrick J Hensley, Roger Li, et al.
Journal of the National Cancer Institute|April 5, 2017
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate CancerLaurent Briollais, Hilmi Ozcelik, Jingxiong Xu, et al.
The Lancet. Digital Health|May 21, 2023
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort studyJethro C C Kwong, Adree Khondker, Eric Meng, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical CystectomyErik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
Pageof 39